Blue Owl Capital Holdings »

Caris Life Sciences shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2026-03-31 $84k 4.7k 17.88

More positions owned by Blue Owl Capital Holdings

Aktis Oncology (AKTS)
Larimar Therapeutics (LRMR)
Engene Holdings
Nuveen Churchill Direct Lend Com Shs (NCDL)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Maplight Therapeutics (MPLT)
Compass Therapeutics (CMPX)
Context Therapeutics (CNTX)
Holley (HLLY)
Eyepoint Com New (EYPT)
Corvus Pharmaceuticals (CRVS)
Conduent Incorporate (CNDT)
Ultragenyx Pharmaceutical (RARE)
Aquestive Therapeutics (AQST)

View all positions for Blue Owl Capital Holdings

Top funds holding Caris Life Sciences

FMR
J. H. Whitney Equity Partners VI
Sixth Street Partners Management Company
Coatue Management
Braidwell
PointState Capital
BlackRock
T. Rowe Price Associates
Vanguard Portfolio Management
Neuberger Berman Group
Vanguard Capital Management
OrbiMed Advisors
UBS Group
Thomas Stevens, CFA"
Duquesne Family Office

View all funds holding Caris Life Sciences